Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target
- 5 September 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Heart Failure Reviews
- Vol. 19 (5), 681-694
- https://doi.org/10.1007/s10741-013-9405-8
Abstract
Heart failure (HF) with preserved ejection fraction (HFPEF) is an increasingly prevalent clinical syndrome with many unresolved issues regarding diagnosis, pathophysiology, and treatment. The major pathophysiological mechanisms underlying HFPEF are known to be fibrosis and reduced ventricular compliance, and hypertension (HTN) is perhaps the most significant risk factor for the development of left ventricular diastolic dysfunction (LVDD). Inflammation is one of the earliest events in cardiac stress situations such as pressure and/or volume overload and involves elevated levels of endothelial adhesion molecules as well as increased production and release of inflammatory cytokines and chemokines in the tissue. The latter promotes the infiltration of activated inflammatory cells, particularly monocytes, into the cardiac tissue. Increased monocyte infiltration is seen in the early and late stages of HTN and HFPEF. Once inside the tissue, monocytes differentiate into macrophages and promote cardiac inflammation, tissue injury, and myocardial fibrosis. This review focuses on inflammation as the initial and primary trigger of ventricular remodelling in HTN and LVDD, affecting progression to HFPEF. The link between inflammation and b-type natriuretic peptide (BNP), a clinical marker of cardiac pressure overload which is positively associated with cardiac dysfunction and HF, is also described. Finally, current and prospective therapeutic approaches for HFPEF based on modification of the inflammatory response are reviewed.Keywords
This publication has 130 references indexed in Scilit:
- Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophyJournal of Molecular and Cellular Cardiology, 2010
- Inflammatory Markers and Incident Heart Failure Risk in Older AdultsJournal of the American College of Cardiology, 2010
- The role of IL-1 in the pathogenesis of heart diseaseArchivum Immunologiae et Therapiae Experimentalis, 2009
- Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnoverEuropean Journal of Heart Failure, 2009
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- C‐reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul StudyEuropean Journal of Heart Failure, 2008
- Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animalsProceedings of the National Academy of Sciences of the United States of America, 2007
- Enhanced activation of pro-inflammatory cytokines in mice lacking natriuretic peptide receptor-APeptides, 2007
- Phosphoinositide 3-kinase γ/δ inhibition limits infarct size after myocardial ischemia/reperfusion injuryProceedings of the National Academy of Sciences of the United States of America, 2006